SIGYN THERAPEUTICS, INC. Earnings Per Share (Basic)
SIGYN THERAPEUTICS, INC. (SIGY) reported Earnings Per Share (Basic) of -$0.36 per share for the 3-month period ending 2025-09-30, per its 10-Q filed 2025-11-14.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasic · last filed 2025-11-14
- SIGYN THERAPEUTICS, INC. earnings per share, basic for the quarter ending 2025-09-30 was -$0.36.
- SIGYN THERAPEUTICS, INC. earnings per share, basic for the quarter ending 2025-06-30 was -$0.90.
- SIGYN THERAPEUTICS, INC. earnings per share, basic for the quarter ending 2025-03-31 was -$0.42.
- SIGYN THERAPEUTICS, INC. earnings per share, basic for the quarter ending 2024-09-30 was -$0.94.
- SIGYN THERAPEUTICS, INC. earnings per share, basic for fiscal 2024 was -$2.51.
- SIGYN THERAPEUTICS, INC. earnings per share, basic for fiscal 2023 was -$3.77.
- SIGYN THERAPEUTICS, INC. earnings per share, basic for fiscal 2022 was -$3.13.
- SIGYN THERAPEUTICS, INC. earnings per share, basic for fiscal 2021 was -$0.08.
| Period end | Earnings Per Share, Basic 3 month | Earnings Per Share, Basic 3 month as first filed | Earnings Per Share, Basic 6 month | Earnings Per Share, Basic 6 month as first filed | Earnings Per Share, Basic 9 month | Earnings Per Share, Basic 9 month as first filed | Earnings Per Share, Basic 12 month | Earnings Per Share, Basic 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2025-09-30 | -$0.36 10-Q · filed 2025-11-14 | -$1.68 10-Q · filed 2025-11-14 | ||||||
| 2025-06-30 | -$0.90 10-Q · filed 2025-09-05 | -$1.32 10-Q · filed 2025-09-05 | ||||||
| 2025-03-31 | -$0.42 10-Q · filed 2025-05-20 | |||||||
| 2024-12-31 | -$2.51 10-K · filed 2025-04-15 | |||||||
| 2024-09-30 | -$0.94 10-Q · filed 2025-11-14 | -$2.26 10-Q · filed 2025-11-14 | ||||||
| 2024-06-30 | -$0.70 10-Q · filed 2025-09-05 | -$1.31 10-Q · filed 2025-09-05 | ||||||
| 2024-03-31 | -$0.62 10-Q · filed 2025-05-20 | |||||||
| 2023-12-31 | -$3.77 10-K · filed 2025-04-15 | |||||||
| 2023-09-30 | -$0.82 10-Q · filed 2024-11-19 | -$0.02 10-Q · filed 2023-11-14 | -$2.83 10-Q · filed 2024-11-19 | -$0.07 10-Q · filed 2023-11-14 | ||||
| 2023-06-30 | -$0.67 10-Q · filed 2024-08-19 | -$0.02 10-Q · filed 2023-08-14 | -$2.02 10-Q · filed 2024-08-19 | -$0.05 10-Q · filed 2023-08-14 | ||||
| 2023-03-31 | -$1.39 10-Q · filed 2024-05-14 | -$0.03 10-Q · filed 2023-05-15 | ||||||
| 2022-12-31 | -$3.13 10-K · filed 2024-02-20 | -$0.08 10-K · filed 2023-03-31 | ||||||
| 2022-09-30 | -$0.02 10-Q · filed 2023-11-14 | -$0.06 10-Q · filed 2023-11-14 | ||||||
| 2022-06-30 | -$0.02 10-Q · filed 2023-08-14 | -$0.04 10-Q · filed 2023-08-14 | ||||||
| 2022-03-31 | -$0.02 10-Q · filed 2023-05-15 | |||||||
| 2021-12-31 | -$0.08 10-K · filed 2023-03-31 | |||||||
| 2021-09-30 | -$0.02 10-Q · filed 2022-11-14 | -$0.05 10-Q · filed 2022-11-14 | ||||||
| 2021-06-30 | -$0.02 10-Q · filed 2022-08-15 | -$0.03 10-Q · filed 2022-08-15 | ||||||
| 2021-03-31 | -$0.01 10-Q · filed 2022-05-13 | |||||||
| 2019-09-30 | -$0.26 derived: net income ÷ weighted average shares · filed 2020-11-09 | -$0.01 derived: net income ÷ weighted average shares · filed 2020-11-09 | -$0.37 derived: net income ÷ weighted average shares · filed 2020-11-09 | |||||
| 2019-06-30 | -$0.00 derived: net income ÷ weighted average shares · filed 2020-08-07 | -$0.00 derived: net income ÷ weighted average shares · filed 2020-08-07 | ||||||
| 2019-03-31 | $0.00 derived: net income ÷ weighted average shares · filed 2020-05-15 | |||||||
| 2018-09-30 | -$0.01 derived: net income ÷ weighted average shares · filed 2019-11-12 | -$0.01 derived: net income ÷ weighted average shares · filed 2019-11-12 | -$0.02 derived: net income ÷ weighted average shares · filed 2019-11-12 | |||||
| 2018-06-30 | -$0.00 derived: net income ÷ weighted average shares · filed 2019-08-05 | -$0.02 derived: net income ÷ weighted average shares · filed 2019-08-05 | ||||||
| 2018-03-31 | -$0.01 derived: net income ÷ weighted average shares · filed 2019-04-19 |